Evidence map›Paper›PMID 42877881›Full record

ReviewThe Journal of clinical and aesthetic dermatology2026

The Effects of Topical and Oral Creatine on Skin Firmness and Resilience: A Review.

Nicole Werpachowski, Lyudmyla Susla, Milana Stein, Karan Lal

Abstract readReview
In one paragraph

Review in The Journal of clinical and aesthetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicole WerpachowskiDr. Werpachowski is with Lenox Hill Hospital, Northwell Health, New York, New York.
Lyudmyla SuslaDr. Susla is with HCA Orange Park Medical Center, Orange Park, Florida.
Milana SteinDr. Stein is with HCA Florida Westside Hospital, Plantation, Florida.
Karan LalDr. Lal is with Affiliated Dermatology, Scottsdale, Arizona.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSkin quality declines with intrinsic aging, environmental damage, and oxidative stress. Loss of skin firmness, a hallmark of aging, results from collagen degradation and fibroblast dysfunction, weakening the extracellular matrix (ECM). This leads to increased laxity and wrinkle formation, known as dermatoporosis. Creatine, a naturally occurring compound essential for cellular energy metabolism, has emerged as a potential agent for improving skin firmness.

objectiveTo examine the effects of topical and oral creatine supplementation on skin firmness, focusing on cellular mechanisms and clinical evidence.

methodsA literature search was conducted in March 2025 using PubMed, Google, and Google Scholar. Studies investigating creatine's effects on the integumentary system were reviewed and summarized.

resultsWhile clinical studies on creatine's effects on skin firmness are limited, in vivo and in vitro research suggest that topical creatine enhances skin elasticity and firmness while providing photoprotective benefits. These effects appear to be achieved with minimal risk when used at recommended doses. Although no direct studies on oral creatine's impact on skin firmness were found, its systemic absorption and demonstrated benefits in other physiologic processes suggest a potential role in skin health. LIMITATIONS: While preliminary findings suggest dermatologic benefits of creatine, research is limited by a lack of studies isolating creatine's effects, scarce in vivo data, and insufficient long-term safety assessments.

conclusionEmerging evidence suggests that both oral and topical creatine may enhance skin firmness by supporting collagen metabolism and fibroblast function. However, further research is needed to establish clinical efficacy.

Indexed as

agingcollagenCreatine supplementationmetabolismoral creatinesafetytopical creatine

Identifiers

PMID42877881
PMCPMC13668104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.